Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Agro

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Cytokine|January 1, 1994
Interaction between oncostatin M, interleukin 1 and prostaglandin E2 in induction of IL-6 expression in human fibroblastsC D Richards, A Agro
Advances in Neuroimmunology|January 1, 1995
Neuroimmunomodulation: classical and non-classical cellular activationA Agro, A M Stanisz
Seminars in Arthritis and Rheumatism|February 1, 1992
Are lymphocytes a target for substance P modulation in arthritis?A Agro, A M Stanisz
Regional Immunology|March 1, 1993
Inhibition of murine intestinal inflammation by anti-substance P antibodyA Agro, A M Stanisz
Endocrinologia Experimentalis|September 1, 1990
Somatostatin-like immunoreactivity in pituitary intraglandular colloid of intermediate lobe originW H Boyd, D Jichici, A Agro
Endocrinologia Experimentalis|December 1, 1990
Intraglandular colloid induced nuclear proliferation of murine thymic cells as determined by flow cytometryW H Boyd, B Kerslake, A Agro
Regional Immunology|November 1, 1989
Neuromodulation of mucosal immunityA M Stanisz, J Bienenstock, A Agro
Regulatory Peptides|February 1, 1991
Immunomodulatory activities of the somatostatin analogue BIM 23014c: effects on murine lymphocyte proliferation and natural killer activityA Agro, I Padol, A M Stanisz
Neuroimmunomodulation|November 1, 1994
Substance-P-mediated intestinal inflammation: inhibitory effects of CP 96,345 and SMS 201-995G Kataeva, A Agro, A M Stanisz
Clinical Therapeutics|October 9, 2001
Cerivastatin versus branded pravastatin in the treatment of primary hypercholesterolemia in primary care practice in Canada: a one-year, open-label, randomized, comparative study of efficacy, safety, and cost-effectivenessR McPherson, K Hanna, A Agro, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Cytokine|January 1, 1994
Interaction between oncostatin M, interleukin 1 and prostaglandin E2 in induction of IL-6 expression in human fibroblastsC D Richards, A Agro
Advances in Neuroimmunology|January 1, 1995
Neuroimmunomodulation: classical and non-classical cellular activationA Agro, A M Stanisz
Seminars in Arthritis and Rheumatism|February 1, 1992
Are lymphocytes a target for substance P modulation in arthritis?A Agro, A M Stanisz
Regional Immunology|March 1, 1993
Inhibition of murine intestinal inflammation by anti-substance P antibodyA Agro, A M Stanisz
Endocrinologia Experimentalis|September 1, 1990
Somatostatin-like immunoreactivity in pituitary intraglandular colloid of intermediate lobe originW H Boyd, D Jichici, A Agro
Endocrinologia Experimentalis|December 1, 1990
Intraglandular colloid induced nuclear proliferation of murine thymic cells as determined by flow cytometryW H Boyd, B Kerslake, A Agro
Regional Immunology|November 1, 1989
Neuromodulation of mucosal immunityA M Stanisz, J Bienenstock, A Agro
Regulatory Peptides|February 1, 1991
Immunomodulatory activities of the somatostatin analogue BIM 23014c: effects on murine lymphocyte proliferation and natural killer activityA Agro, I Padol, A M Stanisz
Neuroimmunomodulation|November 1, 1994
Substance-P-mediated intestinal inflammation: inhibitory effects of CP 96,345 and SMS 201-995G Kataeva, A Agro, A M Stanisz
Clinical Therapeutics|October 9, 2001
Cerivastatin versus branded pravastatin in the treatment of primary hypercholesterolemia in primary care practice in Canada: a one-year, open-label, randomized, comparative study of efficacy, safety, and cost-effectivenessR McPherson, K Hanna, A Agro, et al.
Pageof 3